title: Challenges in Converting Acute Myeloid Leukemia (AML) Genomics Into AML Clinical Trials.
authors.affiliation: Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE.
authors.forename: Emi H
authors.initials: EH
authors.lastname: Caywood
authors.affiliation: Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE eakolb@nemours.org.
authors.forename: E Anders
authors.initials: EA
authors.lastname: Kolb
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D058990:Molecular Targeted Therapy; D009154:Mutation / Q000187:drug effects*; D019009:Proto-Oncogene Proteins c-kit / Q000235:genetics*; D014178:Translocation, Genetic / Q000187:drug effects*; D018631:ras Proteins / Q000235:genetics*
chemical_list: D000970:Antineoplastic Agents; D019009:Proto-Oncogene Proteins c-kit; D018631:ras Proteins